Like the 1920s, the 2020s may have unexpected “exciting consequences,” including new biotech developments thanks to an increased focus on healthcare, reports Forbes.
Health may be further revolutionized by virtue of having attracted the attention of capital markets during the crisis, and it may well be that we see the reemergence of a biotech bubble, and that health care stocks edge out IT companies in quality growth portfolios.
The intersection of healthcare, technology and finance shows how fields are increasingly overlapping.
Read more in Forbes.
